logo
logo

Clario to acquire WCG's eCOA Business

Clario to acquire WCG's eCOA Business

03/10/25, 6:17 PM
Location
https://purecatamphetamine.github.io/country-flag-icons/3x2/US.svgphiladelphia
https://purecatamphetamine.github.io/country-flag-icons/3x2/US.svgnew jersey
Industry
biotechnology
health care
Clario has entered into a definitive agreement to acquire WCG's eCOA Business. This acquisition aims to enhance Clario's service offerings in the clinical trial landscape. With this acquisition, Clario seeks to integrate advanced eCOA solutions into their portfolio. The move is expected to improve the patient data collection process significantly.

Company Info

Company
Clario
Location
Philadelphia, Pennsylvania, United States
Company info
Whether you’re running a cardiac safety, eCOA/ePRO, respiratory or imaging trial, Clario’s Science and Operational teams can advise on how to advance your trial forward. Learn more: https://clario.com/accelerating-clinical-trial-study-setup-time/ Clario is a leading healthcare research and technology company that generates the richest clinical evidence in the industry for our pharmaceutical, biotech and medical device partners. Across decentralized, hybrid and site-based trials, our deep scientific expertise, global scale and the broadest endpoint technology platform in the industry allows our partners to transform lives. Clario has the only technology platform that combines eCOA, cardiac safety, medical imaging, precision motion, and respiratory endpoints. With 30 facilities in nine countries, Clario's global team of science, technology and operational experts has helped deliver over 19,000 trials and 870 regulatory approvals for over five million patients in 120 countries. Our innovation has been transforming clinical trials for 50 years. Visit https://clario.com/ for more information.

Related People